Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand

Por Préville, Xavier, Rittner, Karola, Fend, Laetitia
Publicado no Oncoimmunology (2015)

NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response

Por Oberson, Anne, Spagnuolo, Lorenzo, Puddinu, Viola, Barchet, Winfried, Rittner, Karola, Bourquin, Carole
Publicado no Oncotarget (2017)

Up to 100-Fold Increase of Apparent Gene Expression in the Presence of Epstein-Barr Virus oriP Sequences and EBNA1: Implications of the Nuclear Import of Plasmids

Por Längle-Rouault, Françoise, Patzel, Volker, Benavente, Annie, Taillez, Martine, Silvestre, Nathalie, Bompard, Albine, Sczakiel, Georg, Jacobs, Eric, Rittner, Karola
Publicado em 1998

Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial t...

Por Fend, Laetitia, Gatard-Scheikl, Tanja, Kintz, Jacqueline, Gantzer, Murielle, Schaedler, Emmanuelle, Rittner, Karola, Cochin, Sandrine, Fournel, Sylvie, Préville, Xavier
Publicado no J Immunother Cancer (2014)

TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy

Por Amiset, Laurent, Fend, Laetitia, Gatard-Scheikl, Tania, Rittner, Karola, Duong, Vanessa, Rooke, Ronald, Muller, Sylviane, Bonnefoy, Jean-Yves, Préville, Xavier, Haegel, Hélène
Publicado em 2012

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and M...

Por Remy-Ziller, Christelle, Thioudellet, Christine, Hortelano, Julie, Gantzer, Murielle, Nourtier, Virginie, Claudepierre, Marie-Christine, Sansas, Benoit, Préville, Xavier, Bendjama, Kaïdre, Quemeneur, Eric, Rittner, Karola
Publicado no Hum Vaccin Immunother (2017)

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growt...

Por Kleinpeter, Patricia, Fend, Laetitia, Thioudellet, Christine, Geist, Michel, Sfrontato, Nathalie, Koerper, Véronique, Fahrner, Catherine, Schmitt, Doris, Gantzer, Murielle, Remy-Ziller, Christelle, Brandely, Renée, Villeval, Dominique, Rittner, Karola, Silvestre, Nathalie, Erbs, Philippe, Zitvogel, Laurence, Quéméneur, Eric, Préville, Xavier, Marchand, Jean-Baptiste
Publicado no Oncoimmunology (2016)

Yeast Virus-Derived Stimulator of the Innate Immune System Augments the Efficacy of Virus Vector-Based Immunotherapy

Por Claudepierre, Marie-Christine, Hortelano, Julie, Schaedler, Emmanuelle, Kleinpeter, Patricia, Geist, Michel, Remy-Ziller, Christelle, Brandely, Renée, Tosch, Caroline, Laruelle, Laurence, Jawhari, Anass, Menguy, Thierry, Marchand, Jean-Baptiste, Romby, Pascale, Schultz, Patrick, Hartmann, Gunther, Rooke, Ronald, Bonnefoy, Jean-Yves, Preville, Xavier, Rittner, Karola
Publicado em 2014